NDM-1: The newest superbug?

Nursing

Volumn 42, Issue 4, 2012, Pages 67-68

  Patel, Shilla ^a  

^a SCRIPPS MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE NDM 1; BETA-LACTAMASE NDM-1; CARBAPENEMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; GENETICS; HUMAN; INFECTION CONTROL; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE;

BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE;

EID: 84859299174     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: 10.1097/01.NURSE.0000412934.58501.8c     Document Type: Note

References (8)

1. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791-1798.
2. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011;11(5):355-362.
3. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10(9):597-602.
4. Kaul TK, Chhina DK. Medical tourism and New Delhi metallo-beta-lactamase 1: a concern and threat. J Anaesthesiol Clin Phamacol. 2010;26(4):437-438.
5. Conly J. Antimicrobial resistance: revisiting the "tragedy of the commons." Bull World Health Organ. 2010;88(11):805-806.
6. Walsh TR, Toleman MA. The new medical challenge: why NDM-1? Why Indian? Expert Rev Anti Infect Ther. 2011;9(2):137-141.
7. Quale J, Spelman D. Carbapenemases. UpToDate. http://www.uptodate.com/ contents/ carbapenemases.
8. CDC Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep. 2010;58(10):256-260.